Select Ongoing Trials Currently Enrolling Patients With Breast Cancer.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 10, p. 20
- Publication type:
- Article
Works matching IS 21644403 AND DT 2023 AND VI 13 AND IP 10
Results: 8
1
2
Zanidatamab Demonstrates Efficacy in Refractory HER2-Amplified Biliary Tract Cancer.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 10, p. 18
- Publication type:
- Article
3
Loss of Y Chromosome in Men Makes Bladder Cancer More Aggressive.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 10, p. 16
- By:
- Publication type:
- Article
4
How Nutrition Guidance Can Optimize Fertility Treatments for Female Cancer Survivors: Researchers found 4 main barriers prevented women in the study from achieving a healthy diet.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 10, p. 13
- Publication type:
- Article
5
Crystal S. Denlinger, MD, FACP, Named New CEO of NCCN.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 10, p. 10
- Publication type:
- Article
6
AMA Examines Decade of Change in Physician Practice Ownership and Organization.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 10, p. 1
- Publication type:
- Article
7
Understanding Specialty Pharmacies and Prior Authorizations: The Importance of Standardization.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 10, p. 1
- Publication type:
- Article
8
Massive CAA Shake-up Looming for Health Benefits, Empowering Patients.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 10, p. 1
- By:
- Publication type:
- Article